Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARYAW
2351
CALL
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
| $2.38M | ﹤0.01% |
151,180
-28,820
| -16% | -$94K |
|
2352
Global Industrial
GIC
$1.37B
| $2.38M | ﹤0.01% |
+115,793
| New | +$2.25M |
|
|
CALA
2353
DELISTED
Calithera Biosciences, Inc
CALA
| $2.38M | ﹤0.01% |
22,515
+20,744
| +1,171% | +$2.46M |
|
2354
Alexandria Real Estate Equities
ARE
$8.97B
| $2.38M | ﹤0.01% |
14,645
-197,629
| -93% | -$30.2M |
|
|
YARW
2355
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
| $2.38M | ﹤0.01% |
+381
| New | +$2.58M |
|
|
MRNS
2356
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.37M | ﹤0.01% |
+233,539
| New | +$2.15M |
|
2357
Aldeyra Therapeutics
ALDX
$92.9M
| $2.37M | ﹤0.01% |
567,897
-251,930
| -31% | -$920K |
|
|
SEM
2358
DELISTED
Select Medical
SEM
| $2.36M | ﹤0.01% |
+297,624
| New | +$2.47M |
|
|
B
2359
DELISTED
Barnes Group Inc.
B
| $2.36M | ﹤0.01% |
59,652
+51,035
| +592% | +$1.96M |
|
2360
Heritage Insurance Holdings
HRTG
$889M
| $2.36M | ﹤0.01% |
180,126
+124,299
| +223% | +$1.46M |
|
|
SP
2361
DELISTED
SP Plus Corporation
SP
| $2.35M | ﹤0.01% |
113,710
-125,718
| -53% | -$2.59M |
|
|
DNR
2362
DELISTED
Denbury Resources, Inc.
DNR
| $2.35M | ﹤0.01% |
8,522,683
+8,359,316
| +5,117% | +$2.51M |
|
2363
Broadridge
BR
$17.8B
| $2.35M | ﹤0.01% |
18,622
-6,963
| -27% | -$806K |
|
2364
LeMaitre Vascular
LMAT
$2.32B
| $2.35M | ﹤0.01% |
+88,978
| New | +$2.33M |
|
|
IBKC
2365
DELISTED
IBERIABANK Corp
IBKC
| $2.35M | ﹤0.01% |
51,574
+29,398
| +133% | +$1.21M |
|
2366
CALL
Veeva Systems
VEEV
$33.1B
| $2.34M | ﹤0.01% |
+10,000
| New | +$1.98M |
|
2367
Aurinia Pharmaceuticals
AUPH
$1.91B
| $2.34M | ﹤0.01% |
143,891
-264,205
| -65% | -$4.23M |
|
2368
PUT
WIX.com
WIX
$2.3B
| $2.33M | ﹤0.01% |
9,100
| – | – |
|
2369
Covenant Logistics
CVLG
$894M
| $2.33M | ﹤0.01% |
322,586
+73,900
| +30% | +$377K |
|
|
HSII
2370
DELISTED
Heidrick & Struggles
HSII
| $2.31M | ﹤0.01% |
107,032
+42,518
| +66% | +$936K |
|
2371
Trupanion
TRUP
$1.07B
| $2.31M | ﹤0.01% |
54,124
-29,149
| -35% | -$943K |
|
2372
NETSCOUT
NTCT
$2.96B
| $2.31M | ﹤0.01% |
90,318
+65,406
| +263% | +$1.69M |
|
2373
Mattel
MAT
$4.38B
| $2.31M | ﹤0.01% |
238,718
-373,947
| -61% | -$3.4M |
|
2374
CALL
Glaukos
GKOS
$9.83B
| $2.31M | ﹤0.01% |
+60,000
| New | +$2.23M |
|
2375
Vera Bradley
VRA
$97M
| $2.3M | ﹤0.01% |
518,470
+373,171
| +257% | +$1.86M |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.